Found: 13
Select item for more details and to access through your institution.
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.
- Published in:
- Endocrinology, 2023, v. 164, n. 6, p. 1, doi. 10.1210/endocr/bqad071
- By:
- Publication type:
- Article
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 734, doi. 10.1016/j.clml.2021.05.018
- By:
- Publication type:
- Article
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy.
- Published in:
- Current Oncology, 2024, v. 31, n. 6, p. 3342, doi. 10.3390/curroncol31060254
- By:
- Publication type:
- Article
Therapeutic Management of Chronic Lymphocytic Leukemia Presenting with Recurrent Massive Ascites.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism.
- Published in:
- EJHaem, 2020, v. 1, n. 2, p. 448, doi. 10.1002/jha2.90
- By:
- Publication type:
- Article
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience.
- Published in:
- Oncologist, 2023, v. 28, n. 11, p. e1065, doi. 10.1093/oncolo/oyad118
- By:
- Publication type:
- Article
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 16, p. 3019, doi. 10.1002/cncr.34345
- By:
- Publication type:
- Article
Treating Rosai–Dorfman disease and RAS‐associated autoimmune leucoproliferative disorder with malignant transformation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 667, doi. 10.1111/bjh.17258
- By:
- Publication type:
- Article
Immunoassay Urine Drug Testing among Patients Receiving Opioids at a Safety-Net Palliative Medicine Clinic.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5663, doi. 10.3390/cancers15235663
- By:
- Publication type:
- Article
Adherence to Opioid Patient Prescriber Agreements at a Safety Net Hospital.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2943, doi. 10.3390/cancers15112943
- By:
- Publication type:
- Article
Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 6, p. 947, doi. 10.1002/ijc.34756
- By:
- Publication type:
- Article
Outcomes of patients with intermediate‐risk or poor‐risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 2, p. 387, doi. 10.1002/ijc.33560
- By:
- Publication type:
- Article
Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma.
- Published in:
- BJUI Compass, 2022, v. 3, n. 1, p. 37, doi. 10.1002/bco2.113
- By:
- Publication type:
- Article